Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Increased appetite
2.5 mg/kg), methotrexate (MTX
Dr Mansouri, Dr Adadi and Dr Ratbi recruited the patient and her family, gathered clinical information, prepared DNA samples, and approved the final manuscript as submitted
There is an urgent need for a pharmacological agent that can specifically and safely correct the shared metabolic pathology, ideally by acting at both central (e.g., controlling appetite and cravings) and peripheral (e.g., improving insulin sensitivity, reducing hepatic fat and inflammation) levels to support and enhance existing behavioral strategies, thereby lowering the risk of advanced liver disease development across metabolic and alcoholic etiologies
